{"slideshow_credits": null, "snippet": "Atopic dermatitis causes itching so extreme that many patients consider suicide. In trials, most patients said symptoms waned in the first two weeks of taking a new drug....", "abstract": "Results of two large clinical trials of drug dupilumab, developed to treat uncontrolled, moderate-to-severe atopic dermatitis, type of eczema, are published in New England Journal of Medicine; trials show promising results, with some patients experiencing instantaneous relief from itching that can sometimes be so unbearable patients consider suicide.", "section_name": "Health", "print_page": "13", "document_type": "article", "byline": {"person": [{"firstname": "Gina", "role": "reported", "lastname": "KOLATA", "rank": 1, "organization": ""}], "original": "By GINA KOLATA"}, "web_url": "http://www.nytimes.com/2016/10/01/health/severe-eczema-atopic-dermatitis-drug.html", "lead_paragraph": "Atopic dermatitis causes itching so extreme that many patients consider suicide. In trials, most patients said symptoms waned in the first two weeks of taking a new drug.", "headline": {"main": "New Drug for Severe Eczema Is Successful in 2 New Trials", "print_headline": "2 Trials Show New Treatment for Severe Eczema Can Provide Swift Relief"}, "_id": "57ef510095d0e021d79897e7", "word_count": "1201", "multimedia": [{"height": 126, "url": "images/2016/10/01/science/01SKIN/01SKIN-thumbWide.jpg", "legacy": {"wideheight": "126", "wide": "images/2016/10/01/science/01SKIN/01SKIN-thumbWide.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 438, "url": "images/2016/10/01/science/01SKIN2/01SKIN2-articleLarge.jpg", "legacy": {"xlarge": "images/2016/10/01/science/01SKIN2/01SKIN2-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "438"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2016/10/01/science/01SKIN/01SKIN-thumbStandard-v2.jpg", "legacy": {"thumbnail": "images/2016/10/01/science/01SKIN/01SKIN-thumbStandard-v2.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2016-10-01T04:00:00+0000", "source": "The New York Times", "news_desk": "National", "keywords": [{"name": "subject", "value": "Eczema", "is_major": "Y", "rank": "1"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "is_major": "Y", "rank": "2"}, {"name": "organizations", "value": "Food and Drug Administration", "is_major": "N", "rank": "3"}, {"name": "organizations", "value": "Sanofi SA", "is_major": "N", "rank": "5"}, {"name": "organizations", "value": "Regeneron Pharmaceuticals Inc", "is_major": "N", "rank": "6"}, {"name": "organizations", "value": "New England Journal of Medicine", "is_major": "Y", "rank": "7"}, {"name": "subject", "value": "Research", "is_major": "N", "rank": "8"}], "blog": [], "subsection_name": null, "type_of_material": "News"}